2023 - Research.com Microbiology in United Kingdom Leader Award
2022 - Research.com Microbiology in United Kingdom Leader Award
Fellow of The Academy of Medical Sciences, United Kingdom
Fellow of the European Confederation of Medical Mycology (ECMM)
His primary areas of study are Aspergillosis, Itraconazole, Mycosis, Microbiology and Surgery. His work carried out in the field of Aspergillosis brings together such families of science as Amphotericin B, Voriconazole, Aspergillus and Allergic bronchopulmonary aspergillosis. His Itraconazole research includes elements of Azole, Ketoconazole, Fluconazole, Pharmacology and Drug resistance.
His Mycosis research is multidisciplinary, incorporating elements of Oral administration, Epidemiology, Neutropenia, Complication and Transplantation. His work is dedicated to discovering how Surgery, Internal medicine are connected with Gastroenterology and other disciplines. His Chronic pulmonary aspergillosis study combines topics from a wide range of disciplines, such as COPD and Intensive care medicine.
His scientific interests lie mostly in Aspergillosis, Microbiology, Internal medicine, Chronic pulmonary aspergillosis and Immunology. His Aspergillosis research integrates issues from Incidence, Epidemiology, Allergic bronchopulmonary aspergillosis, Intensive care medicine and Mycosis. David W. Denning interconnects Neutropenia and Chemotherapy in the investigation of issues within Mycosis.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Surgery. In Chronic pulmonary aspergillosis, he works on issues like Tuberculosis, which are connected to Histoplasmosis. Within one scientific family, David W. Denning focuses on topics pertaining to Amphotericin B under Itraconazole, and may sometimes address concerns connected to Minimum inhibitory concentration.
Aspergillosis, Chronic pulmonary aspergillosis, Internal medicine, Allergic bronchopulmonary aspergillosis and Incidence are his primary areas of study. His Aspergillosis research is multidisciplinary, incorporating perspectives in Epidemiology, Aspergillus, Intensive care medicine, Lung and Fungal keratitis. Chronic pulmonary aspergillosis is a primary field of his research addressed under Immunology.
His Internal medicine study combines topics in areas such as Gastroenterology, Itraconazole and Voriconazole. His study in Itraconazole is interdisciplinary in nature, drawing from both Dermatology and Amphotericin B. His Allergic bronchopulmonary aspergillosis research includes themes of Sputum and Asthma.
His primary areas of investigation include Aspergillosis, Chronic pulmonary aspergillosis, Aspergillus, Tuberculosis and Epidemiology. The concepts of his Aspergillosis study are interwoven with issues in Pneumocystis pneumonia, Internal medicine and Voriconazole. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology.
His Chronic pulmonary aspergillosis research incorporates elements of Tinea capitis, Serology, Pediatrics and Allergic bronchopulmonary aspergillosis. He has included themes like Aspergillus fumigatus, Immunology and Lung in his Aspergillus study. His Itraconazole research incorporates themes from Medical microbiology, Amphotericin B and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht.
Clinical Infectious Diseases (2008)
Hidden Killers: Human Fungal Infections
Gordon D. Brown;David W. Denning;Neil A. R. Gow;Stuart M. Levitz.
Science Translational Medicine (2012)
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett.
Clinical Infectious Diseases (2002)
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America
Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman.
Clinical Infectious Diseases (2016)
Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus
William C. Nierman;William C. Nierman;Arnab Pain;Michael J. Anderson;Jennifer R. Wortman;Jennifer R. Wortman.
Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae
James E. Galagan;Sarah E. Calvo;Christina Cuomo;Li Jun Ma.
Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis
Radha Rajasingham;Rachel M Smith;Benjamin J Park;Joseph N Jarvis.
Lancet Infectious Diseases (2017)
Genome sequencing and analysis of Aspergillus oryzae
Masayuki Machida;Kiyoshi Asai;Motoaki Sano;Toshihiro Tanaka.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: